BAM
Brave Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.9K | Hold |
11,433
| – | – | 0.02% | 150 |
|
|
2025
Q1 | $60.5K | Hold |
11,433
| – | – | 0.02% | 140 |
|
|
2024
Q4 | $77.3K | Buy |
11,433
+1,433
| +14% | +$9.69K | 0.02% | 144 |
|
|
2024
Q3 | $65.9K | Hold |
10,000
| – | – | 0.02% | 148 |
|
|
2024
Q2 | $75K | Hold |
10,000
| – | – | 0.02% | 140 |
|
|
2024
Q1 | $99.7K | Sell |
10,000
-5,000
| -33% | -$49.9K | 0.03% | 142 |
|
|
2023
Q4 | $148K | Buy |
+15,000
| New | +$148K | 0.04% | 132 |
|